FRANCE – Coave Therapeutics, a clinical-stage biotechnology company, has received funding worth US$39m from eureKARE , a pioneering new company focused on financing and building next generation biotechnology companies, during…
Read MoreCoave Therapeutics receives €33m (US$39m) worth of funding to help execute its corporate strategy
